Vivani Medical (VANI) Share-based Compensation (2014 - 2026)
Vivani Medical (VANI) posted quarterly Share-based Compensation of $100000.0 for Q1 2026, down 71.43% year-over-year from $350000.0 in Q1 2025, and down 78.59% quarter-over-quarter from $467000.0 in Q4 2025.
Vivani Medical (VANI) Share-based Compensation (2014 - 2026) Analysis & Trends
Vivani Medical's Share-based Compensation history runs 13 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 71.43% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $100000.0 (down 93.78% YoY), while the FY2025 annual figure was $1.5 million, down 7.83% from the prior year.
- Share-based Compensation for Q1 2026 stood at $100000.0, down from $467000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $1.9 million in Q4 2023, with the low at $511.0 in Q3 2023.
- The 5-year median for Share-based Compensation is $369000.0 (2023), against an average of $396860.6.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation sank 99.87% in 2023, then jumped 92267.91% in 2024.
- Vivani Medical's Share-based Compensation stood at $171000.0 in 2022, then soared by 989.24% to $1.9 million in 2023, then plunged by 78.42% to $402000.0 in 2024, then climbed by 16.17% to $467000.0 in 2025, then slumped by 78.59% to $100000.0 in 2026.
- Business Quant data shows VANI's Share-based Compensation at $100000.0 in Q1 2026, $467000.0 in Q4 2025, and $300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 313,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 313,000.00 |
| Jun 30, 2026 | 313,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 467,000.00 |
| Dec 31, 2025 | 467,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Mar 31, 2025 | 350,000.00 |
| Mar 31, 2025 | 350,000.00 |
| Dec 31, 2024 | 402,000.00 |
| Dec 31, 2024 | 402,000.00 |
| Sep 30, 2024 | 472,000.00 |
| Sep 30, 2024 | 472,000.00 |
| Jun 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 383,000.00 |
| Mar 31, 2024 | 353,000.00 |
| Mar 31, 2024 | 353,000.00 |